Keck School of Medicine of USC

 Molecular Microbiology and Immunology

Zika proteins responsible for microcephaly identified

August 11th, 2016|

USC researchers have identified two Zika proteins potentially responsible for thousands of microcephaly cases in Brazil and elsewhere — taking one small step toward preventing Zika-infected mothers from birthing babies with abnormally small heads.

The Zika virus contains 10 proteins, but only NS4A and NS4B matter when it comes to microcephaly, according to a USC-led study published

In Memoriam: Gunther Dennert, 78

July 20th, 2016|

Former chair of the Department of Molecular Microbiology and Immunology at the Keck School of Medicine of USC, Gunther Dennert, PhD, passed away on June 5, after a long battle with pancreatic cancer.

Dennert was widely known and respected for his work as an original and creative immunologist. In his work, he focused on immune regulation

‘Sunscreen’ gene may help protect against skin cancer

July 1st, 2016|

A new study has identified a “sunscreen” gene that may help stave off skin cancer.

The team, led by researchers from the Keck School of Medicine of USC, found that the “UV radiation Resistance Associated Gene” is a tumor suppressor for skin cancer, which is the most common form of cancer in the United States. Melanoma is

Caution urged at Zika symposium

June 22nd, 2016|

Scientists and public officials warned residents of health risks and provided mosquito-abatement tips during the Zika Virus Awareness Symposium, held June 9 at the Aresty Auditorium on the Health Sciences Campus.

Lecture topics ranged from the control, diagnosis and treatment of the Zika virus and how this epidemic may affect the Los Angeles area as well

Baxter Foundation visits Health Sciences Campus

June 5th, 2016|

Directors of the Donald E. and Delia B. Baxter Foundation visited the USC Health Sciences Campus on May 9, to hear presentations from Keck School of Medicine of USC faculty and meet with participants in the Baxter Foundation Student Research Fellowship Program. The Donald E. and Delia B. Baxter Foundation recently gave $300,000 to the

USC study paves path to a cure for chronic HBV infection

May 3rd, 2016|

The infection has been cured in mice by removing “traitors” residing in liver’s immune cells.

Chronic hepatitis B infection, a lifetime disease with no effective cure, could one day be cleared from a person’s system with a series of shots, according to a new USC study.

Most healthy adults infected with HBV will develop protective immunity, healing

USC Stem Cell scientists enter the conversation about CRISPR

May 3rd, 2016|

CRISPR-Cas9 is a gene-editing technique that enables scientists to disable, replace or modify sections of DNA. It allows for unprecedented precision and speed in the field of genome editing. It has been used to create micropigs to be sold as pets and to try to eradicate HIV infection in humans.

The scientific community is concerned about altering human embryos to create

Jae Jung, PhD, wins prestigious outstanding investigator award from National Cancer Institute

March 22nd, 2016|

Jae Jung Lab in the Department of Molecular Microbiology and Immunology to receive over $7 million to investigate the development and prevention of Kaposi’s sarcoma.

Distinguished Professor Jae Jung, PhD, chair of the Department of Molecular Microbiology & Immunology and the director of the University of Southern California (USC) Institute for Emerging Pathogens and Immune Diseases

New joint postdoctoral program unites Keck researchers with industry partner to solve immune diseases

January 22nd, 2016|

Professor Omid Akbari points out a finding in his research of immune diseases.Investigators at the Keck School of Medicine of USC are tackling immune-mediated diseases in a whole new way with the creation of a joint postdoctoral program.

Omid Akbari, PhD, a professor in the Department of Molecular Microbiology and Immunology at the Keck School of

Scientists root out the “bad seeds” of liver cancer

January 8th, 2016|

Researchers have found the “bad seeds” of liver cancer and believe they could one day reprogram them to remain responsive to cancer treatment, a new study has found.

The key to disrupting the chemo-resistant stem cells that become liver tumors is to target the stem cell marker NANOG, said senior author Keigo Machida, PhD, associate professor